Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Patient Education Materials for Non-English Speakers

Katie Robinson  |  Issue: July 2023  |  

The Vasculitis Foundation hopes to continue its series to better serve all Spanish-speaking patients in the Americas and beyond. “The hope is that Aprendiendo de Vasculitis continues to grow, and hopefully expands into initiatives in other languages,” Dr. Sattui says. “Access to patient information is crucial and this should be available to all patients, independent of any language barriers.”

Katie Robinson is a medical writer based in New York.

ADVERTISEMENT
SCROLL TO CONTINUE

Reference

  1. U.S. Department of Health and Human Services. Office of the Surgeon General. Health Literacy Reports and Publications.

Related Articles
    Hanna Kuprevich / shutterstock.com

    How to Help Your Patients Find Credible Information about Their Disease

    Where can patients obtain more information about their diagnoses and prescription drugs, and answers to the assortment of questions they have about living with a chronic disease once they leave the rheumatologist office? Patient education materials can be found in many places on the internet, but those looking for answers may need a helping hand…

    Fall 2021’s Awards, Appointments & Announcements in Rheumatology

    Jeffrey Siegel, MD, Assumes New Position as Director for New Office of Drug Evaluation Sciences at the FDA On Feb. 16, Jeffrey Siegel, MD, became the director of the recently created Office of Drug Evaluation Sciences at the U.S. Food & Drug Administration (FDA). The move, he says, “puts together many of the different things…

    ilusmedical / shutterstock.com

    The State of Clinical Research in Vasculitis: 2021

    It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab…